The prize, created in 2008 by a number of technology-oriented German companies and the AHK Tokyo, was awarded for Ikeya’s work on “Research on drug discovery for progressive ossification fibrosis dysplasia (FOP) utilizing disease-specific iPS cells”.

CiRA news release, June 29, 2018